MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients

Abstract Purpose The prognostic factors for diffuse large B‐cell lymphoma (DLBCL) have been fully explored, but prognostic information for bulky mass DLBCL patients is limited. This study aimed to analyze the prognostic value of MYC protein expression and other biological parameters in bulky mass DL...

Full description

Bibliographic Details
Main Authors:	Yanjie Wang, Donglin Liu, Xudong Zhang, Mingzhi Zhang, Shenglei Li, Xiaoyan Feng, Meng Dong, Shanshan Ma, Siyu Qian, Zeyuan Wang, Yue Zhang, Pengyuan Wang, Shuhao Mei, Qingjiang Chen
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Series:	Cancer Medicine
Subjects:	diffuse large B‐cell lymphoma bulky mass immunohistochemistry lymphoma MYC radiotherapy
Online Access:	https://doi.org/10.1002/cam4.6463

Similar Items

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
by: Julum Nwanze, et al.
Published: (2017-09-01)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
by: Weiping Li, et al.
Published: (2019-07-01)

Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma
by: Aydan KILIÇARSLAN, et al.
Published: (2018-09-01)

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
by: Zhenming Cai, et al.
Published: (2020-06-01)

MYC’s Fine Line Between B Cell Development and Malignancy
by: Oriol de Barrios, et al.
Published: (2020-02-01)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification
by: Masashi Miyaoka, et al.
Published: (2022-11-01)

Redefining the high‐grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report
by: Socorro María Rodríguez‐Pinilla, et al.
Published: (2022-02-01)

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
by: Giulio Donati, et al.
Published: (2023-06-01)

High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
by: Cheng-Chih Tsai, et al.
Published: (2021-03-01)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
by: Ekaterina Mikhailovna Stasevich, et al.
Published: (2022-04-01)

Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma
by: René Winkler, et al.
Published: (2022-12-01)

Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques
by: Elisabetta Maria Abenavoli, et al.
Published: (2023-03-01)

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
by: Hui Liu, et al.
Published: (2021-12-01)

Crosstalk Between MYC and lncRNAs in Hematological Malignancies
by: Kaifee Arman, et al.
Published: (2020-10-01)

Alternative <i>c-MYC</i> mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
by: Dina Ibrahim, et al.
Published: (2022-06-01)

Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort
by: Bogyeong Han, et al.
Published: (2020-11-01)

Bulky cutaneous metastasis from lung cancer
by: Giuseppe Famularo, et al.
Published: (2018-04-01)

Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
by: Daniel F. Liefwalker, et al.
Published: (2021-08-01)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
by: YunXiang Zhang, et al.
Published: (2019-01-01)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
by: Candace J. Poole, et al.
Published: (2018-11-01)

Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01)

Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
by: A. Vera de Jonge, et al.
Published: (2020-10-01)

Expression of PD-L1 and Its Clinical Significance in MYC/BCL2 Double-expression Large B Cell Lymphoma
by: WANG Ping, et al.
Published: (2020-01-01)

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
by: Alison M. Moore, et al.
Published: (2018-05-01)

Autologous hematopoietic stem cell transplantation as first‐line consolidation therapy can improve the prognosis of diffuse large B‐cell lymphoma with high expression of MYC protein
by: Kai Hu, et al.
Published: (2019-07-01)

Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
by: Said Izreig, et al.
Published: (2020-05-01)

The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
by: Mutaz Jamal Al-Khreisat, et al.
Published: (2022-06-01)

High‐grade B‐cell lymphoma with MYC and BCL2 rearrangements with abundant multinucleated giant tumor cells
by: Man Zhang, et al.
Published: (2023-05-01)

Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis
by: Stephanie Grabow, et al.
Published: (2016-03-01)

Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma
by: Xiaohu Huang, et al.
Published: (2021-02-01)

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells
by: Emilia Białopiotrowicz, et al.
Published: (2020-03-01)

Germinal Centre B Cell Functions and Lymphomagenesis: Circuits Involving MYC and MicroRNAs
by: Marcela Cristina Robaina, et al.
Published: (2019-10-01)

MYC function and regulation in physiological perspective
by: Rajiv Kumar Jha, et al.
Published: (2023-10-01)

HIV Nef enhances the expression of oncogenic c-MYC and activation-induced cytidine deaminase in Burkitt lymphoma cells, promoting genomic instability
by: Nontlantla Mdletshe, et al.
Published: (2020-09-01)

Differential Transcriptional Reprogramming by Wild Type and Lymphoma-Associated Mutant MYC Proteins as B-Cells Convert to a Lymphoma Phenotype
by: Amir Mahani, et al.
Published: (2021-12-01)

Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma
by: Chuquan Shang, et al.
Published: (2023-09-01)

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma
by: Marion Lacroix, et al.
Published: (2023-03-01)

Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
by: Vanja Zeremski, et al.
Published: (2023-07-01)

Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma
by: Yi Gong, et al.
Published: (2017-06-01)

Review: proteins c-Myc and Myc-nick as potential targets for the melignant melanoma treatment
by: G. Maryniuk, et al.
Published: (2023-07-01)